Who
Robert J. Perez
Director
Company insider
Files Form 4 as: Director, Rapport Therapeutics; Director, Vir Biotechnology; Director, Third Harmonic Bio; Director, Spark Therapeutics; Director, Larimar Therapeutics; Director, Cogent Biosciences; Director, Amag Pharmaceuticals; Director, Decoy Therapeutics.
In numbers
- Trades disclosed
- 267
- Buys
- 1
- Sells
- 29
- Bought
- $80K
- Sold
- $15.5M
- Companies
- 11
- Companies where not an officer
- 10
- First trade
- 12 Jan 2004
- Last trade
- 10 Jun 2026
- Last filed
- 10 Jun 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 10 Jun 2026filed 10 Jun 2026 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,200 at $0.00 | filing |
| 10 Jun 2026filed 10 Jun 2026 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —15,200 at $0.00 | filing |
| 17 Jun 2025filed 18 Jun 2025 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,925 at $0.00 | filing |
| 7 Nov 2024filed 7 Nov 2024 | RAPP Rapport Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —29,756 at $0.00 | filing |
| 22 May 2023filed 24 May 2023 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,054 at $0.00 | filing |
| 22 May 2023filed 24 May 2023 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —6,027 at $0.00 | filing |
| 6 Mar 2023filed 8 Mar 2023 | Third Harmonic Biooption or derivative | SEC FORM 4 Code D | —13,667 | filing |
| 6 Mar 2023filed 8 Mar 2023 | Third Harmonic Biooption or derivative | SEC FORM 4 Code A | —13,667 | filing |
| 26 Oct 2022filed 27 Oct 2022 | Third Harmonic Biooption or derivative | SEC FORM 4 Code A | —13,667 at $0.00 | filing |
| 23 May 2022filed 25 May 2022 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —12,810 at $0.00 | filing |
| 23 May 2022filed 25 May 2022 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —6,405 at $0.00 | filing |
| 21 May 2021filed 25 May 2021 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,748 at $0.00 | filing |
| 21 May 2021filed 25 May 2021 | VIR Vir BiotechnologyBiotechnology | SEC FORM 4 Code A | —3,374 at $0.00 | filing |
| 21 May 2020filed 13 Oct 2020 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —24,567 at $0.00 | filing |
| 21 May 2020filed 26 May 2020 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —28,888 at $0.00 | filing |
| 17 Dec 2019filed 17 Dec 2019 | Spark Therapeuticsoption or derivative | SEC FORM 4 Code D | —4,000 at $0.00 | filing |
| 17 Dec 2019filed 17 Dec 2019 | Spark Therapeuticsoption or derivative | SEC FORM 4 Code D | —8,000 at $0.00 | filing |
| 17 Dec 2019filed 17 Dec 2019 | Spark Therapeuticsoption or derivative | SEC FORM 4 Code D | —2,000 at $0.00 | filing |
| 17 Dec 2019filed 17 Dec 2019 | Spark Therapeutics | SEC FORM 4 Code U | $286K2,500 at $114.50 | filing |
| 10 Oct 2019filed 10 Oct 2019 | VIR Vir Biotechnologyoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,222 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
Related people
Nobody else traded the same names lately.